KMT2C and KMT2D are both among the 10 most mutated genes in cancer (20% of all cancers).77 Our results present KMT2C/D as one of a few known regulators of RT, expanding its functional spectrum beyond transcriptional regulation. The gene discussed is KMT2C; the disease is cancer.